Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,643 SEK | +1.08% | -1.76% | +21.39% |
06-02 | Astra's Enhertu breast cancer trial shows 'unprecedented' results | RE |
06-02 | Astra's Enhertu delays breast cancer in patients with low HER2 levels | RE |
- Stock Market
- Equities
- AZN Stock
- AZN Stock
- News AstraZeneca PLC
- Analyst Reco.